Somatic BRAF and NRAS mutations in familial melanomas with known germline CDKN2A status: a GenoMEL study

J Invest Dermatol. 2014 Jan;134(1):287-290. doi: 10.1038/jid.2013.270. Epub 2013 Jun 14.

¹ Department of Oncology-Pathology, Cancer Center Karolinska, Karolinska Institutet, Stockholm, Sweden.
² Department of Dermatology, Leiden University Medical Centre, Leiden, The Netherlands.
³ Department of Internal Medicine and Medical Specialties, University of Genoa and Laboratory of Genetics of Rare Hereditary Cancers, IRCCS San Martino-IST Research Hospital, Genoa, Italy.
⁴ Department of Oncology, Clinical Sciences, Lund University, Lund, Sweden.
⁵ Latvian Biomedical Research and Study Centre, Riga, Latvia.
⁶ Melanoma Unit, Department of Dermatology, Hospital Clinic, University of Barcelona, IDIBAPS and CIBER de Enfermedades Raras, Barcelona, Spain.
⁷ Section of Epidemiology and Biostatistics, Cancer Research UK Clinical Centre, Leeds Institute of Molecular Medicine, University of Leeds, Leeds, UK.
⁸ Queensland Institute of Medical Research, Brisbane, Queensland, Australia.
⁹ Karolinska University Hospital, Dermatologic Diagnostic Centrum Solna, Stockholm, Sweden.
¹⁰ Department of Oncology-Pathology, Cancer Center Karolinska, Karolinska Institutet, Stockholm, Sweden. Electronic address: [email protected].

No abstract available

Publication types